| ABPA | Allergic |
| BA | Broncho-alveolar |
| BMI | Body mass index |
| CGM | Continuous glucose monitoring |
| CF | Cystic Fibrosis |
| CFRD | Cystic Fibrosis-related diabetes |
| CFTR | Cystic Fibrosis transmembrane conductance regulator |
| CFTRm | CFTR Modulator(s) |
| CT | Computed Tomography |
| ECFSPR | European Cystic Fibrosis Society Patient Registry |
| ETI | Elexacaftor/Tezacaftor/Ivacaftor |
| HbA1c | Hemoglobin A1c |
| IVA | Ivacaftor |
| LCI | Lung Clearance Index |
| LUM | Lumacaftor |
| MeSH | Medical Subject Headings |
| Pa | Pseudomonas aeruginosa |
| PERT | Pancreatic enzyme replacement therapy |
| PEx | Pulmonary Exacerbations |
| ppFEV1 | percent predicted forced expiratory volume in one second |
| RCT | Randomized controlled trials |